Literature DB >> 14693710

Mode of onset of type 2 diabetes from normal or impaired glucose tolerance.

Ele Ferrannini1, Monica Nannipieri, Ken Williams, Clicerio Gonzales, Steve M Haffner, Michael P Stern.   

Abstract

Fasting plasma glucose concentrations (FPG) predict development of type 2 diabetes. Whether hyperglycemia evolves from normoglycemia gradually over time or as a step increase is not known. We measured plasma glucose and insulin levels during oral glucose testing in 35- to 64-year-old men and nonpregnant women from a population-based survey (Mexico City Diabetes Study) at baseline (n = 2,279) and after 3.25 (n = 1,740) and 7 years (n = 1,711) of follow-up. In subjects with normal glucose tolerance (NGT) on all three occasions (nonconverters; n = 911), FPG increased only slightly (0.23 +/- 0.79 mmol/l, mean +/- SD; P < 0.0001) over 7 years. In contrast, conversion to diabetes among NGT subjects (n = 98) was marked by a large step-up in FPG regardless of time of conversion (3.06 +/- 2.57 and 2.94 +/- 3.11 mmol/l, respectively, at 3.25 and 7 years; P < 0.0001 vs. nonconverters). Likewise, in subjects who converted to diabetes from impaired glucose tolerance (n = 75), FPG rose by 3.14 +/- 3.83 and 3.12 +/- 3.61 mmol/l (P < 0.0001 vs. nonconverters). Three-quarters of converters had increments in FPG above the 90th percentile of the corresponding increments in nonconverters. Converters had higher baseline BMI (30.4 +/- 4.9 vs. 27.3 +/- 4.0 kg/m(2); P < 0.001) and fasting plasma insulin values (120 +/- 78 vs. 84 +/- 84 pmol/l; P < 0.02) than nonconverters; however, no consistent change in either parameter had occurred before conversion. In contrast, changes in 2-h postglucose insulin levels between time of conversion and preceding measurement were significantly (P < 0.0001) related to the corresponding changes in FPG in an inverse manner. We conclude that, within a 3-year time frame, the onset of diabetes is very often rapid rather than gradual and is in part explained by a fall in glucose-stimulated insulin response.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14693710     DOI: 10.2337/diabetes.53.1.160

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  47 in total

1.  Strategies for preventing type 2 diabetes: an update for clinicians.

Authors:  Kaivan Khavandi; Halima Amer; Bashar Ibrahim; Jack Brownrigg
Journal:  Ther Adv Chronic Dis       Date:  2013-09       Impact factor: 5.091

2.  Diurnal rhythm in endogenous glucose production is a major contributor to fasting hyperglycaemia in type 2 diabetes. Suprachiasmatic deficit or limit cycle behaviour?

Authors:  J Radziuk; S Pye
Journal:  Diabetologia       Date:  2006-05-16       Impact factor: 10.122

3.  Progression from newly acquired impaired fasting glusose to type 2 diabetes.

Authors:  Gregory A Nichols; Teresa A Hillier; Jonathan B Brown
Journal:  Diabetes Care       Date:  2007-02       Impact factor: 19.112

4.  Insulin resistance versus beta-cell dysfunction in the pathogenesis of type 2 diabetes.

Authors:  Ele Ferrannini
Journal:  Curr Diab Rep       Date:  2009-06       Impact factor: 4.810

5.  Reducing the prevalence of dysglycemia: is the time ripe to test the effectiveness of intervention in high-risk individuals with elevated 1 h post-load glucose levels?

Authors:  Michael Bergman; Ram Jagannathan; Martin Buysschaert; Jose Luis Medina; Mary Ann Sevick; Karin Katz; Brenda Dorcely; Jesse Roth; Angela Chetrit; Rachel Dankner
Journal:  Endocrine       Date:  2017-01-25       Impact factor: 3.633

6.  Relations of insulin resistance and glycemic abnormalities to cardiovascular magnetic resonance measures of cardiac structure and function: the Framingham Heart Study.

Authors:  Raghava S Velagaleti; Philimon Gona; Michael L Chuang; Carol J Salton; Caroline S Fox; Susan J Blease; Susan B Yeon; Warren J Manning; Christopher J O'Donnell
Journal:  Circ Cardiovasc Imaging       Date:  2010-03-05       Impact factor: 7.792

7.  Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study.

Authors:  Adam G Tabák; Markus Jokela; Tasnime N Akbaraly; Eric J Brunner; Mika Kivimäki; Daniel R Witte
Journal:  Lancet       Date:  2009-06-08       Impact factor: 79.321

8.  Progression to diabetes in relatives of type 1 diabetic patients: mechanisms and mode of onset.

Authors:  Ele Ferrannini; Andrea Mari; Valentina Nofrate; Jay M Sosenko; Jay S Skyler
Journal:  Diabetes       Date:  2009-12-22       Impact factor: 9.461

9.  Plasma glucose levels as predictors of diabetes: the Mexico City diabetes study.

Authors:  E Ferrannini; M Massari; M Nannipieri; A Natali; R Lopez Ridaura; C Gonzales-Villalpando
Journal:  Diabetologia       Date:  2009-02-18       Impact factor: 10.122

10.  Defining and characterizing the progression of type 2 diabetes.

Authors:  Vivian A Fonseca
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.